GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (TSXV:SBM) » Definitions » ROE % Adjusted to Book Value

Sirona Biochem (TSXV:SBM) ROE % Adjusted to Book Value : 0.00% (As of Jul. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Sirona Biochem ROE % Adjusted to Book Value?

Sirona Biochem's ROE % for the quarter that ended in Jul. 2024 was 0.00%. Sirona Biochem's PB Ratio for the quarter that ended in Jul. 2024 was N/A. Sirona Biochem's ROE % Adjusted to Book Value for the quarter that ended in Jul. 2024 was N/A.


Sirona Biochem ROE % Adjusted to Book Value Historical Data

The historical data trend for Sirona Biochem's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem ROE % Adjusted to Book Value Chart

Sirona Biochem Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -46.39 -

Sirona Biochem Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sirona Biochem's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Sirona Biochem's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sirona Biochem's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirona Biochem's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Sirona Biochem's ROE % Adjusted to Book Value falls into.



Sirona Biochem ROE % Adjusted to Book Value Calculation

Sirona Biochem's ROE % Adjusted to Book Value for the fiscal year that ended in Oct. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Sirona Biochem's ROE % Adjusted to Book Value for the quarter that ended in Jul. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sirona Biochem ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirona Biochem Business Description

Traded in Other Exchanges
Address
C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L4
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. The company has a business presence in Canada and France.
Executives
Christopher Hopton Director
Howard Jarman Verrico Director, Senior Officer

Sirona Biochem Headlines